熱門資訊> 正文
上诉法院恢复牙科矫正公司反垄断指控，Align Technology受到打击
2026-10-06 04:22
- Align Technology (ALGN), the maker of Invisalign, was dealt a blow on Monday after a federal appeals court reversed a lower court ruling that granted the company summary judgment.
- The decision means that Align will likely again face claims that it held a monopoly for clear dental aligners. The company was sued by consumers and dental practices.
- The US Court of Appeals for the Ninth Circuit found that the lower court made a mistake as plaintiffs provided sufficient evidence that Align minimized competition for their aligners as well as digital image scanners used to make the aligners by measuring a patient's jaw, teeth, and bite, Bloomberg Law reported.
More on Align Technology
- Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript
- Align Technology: DCF Signals Overvaluation Despite Long-Term Growth Potential
- Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
- 10 large and mega-cap U.S. healthcare stocks with the weakest momentum grades
- Align wins China patent ruling against Angelalign
推薦文章
美股前瞻 | 美債收益率攀升壓制期指！市場靜候聯儲局會議紀要；SpaceX將融400億美元買英偉達芯片；英特爾將繼續參與Terafab項目
新股申購 | 「非洲手機之王」傳音控股今啟招股！一手入場費3919.13港元
10月7日外盤頭條：Anthropic擴大先進AI模型訪問權限 Meta和沃爾瑪制定個人代理協議 法國25萬人參加抗議活動
Meta推出Muse利好AMD，AI浪潮重心轉向個人智能代理
美股前瞻 | 三大期指齊升，納指開盤勢再創新高！大摩看高SpaceX至300美元；AMD蘇姿豐喊話將持續大幅擴產；邁威爾科技21點舉行投資者日
一圖看懂 | 潘渡SOL ETF開啟申購！緊密追蹤Solana價格表現
Anthropic營收增長面臨挑戰，微軟和Meta據悉限制員工使用Claude模型
30年期收益率本月將破6%？經濟韌性與通脹壓力推高利率 美債拋售潮進一步加劇
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
